Reply to: Life-threatening anaphylaxis to peanut — impossible to predict?
Santos, A. F., Evans, E., O'Rourke, C., Bahnson, H. T., Lack, G.
Santos, A. F., Evans, E., O'Rourke, C., Bahnson, H. T., Lack, G. (2022). Reply to: Life-threatening anaphylaxis to peanut — impossible to predict?. Journal of Allergy and Clinical Immunology, 149 (3), 1129-1131.
The Prevention of Milk Allergy and the Risks of Stopping Too Soon
Huffaker M
Huffaker M (2022). The Prevention of Milk Allergy and the Risks of Stopping Too Soon. J Allergy Clin Immunol Pract, 10 (1), 180-181.
Allergen immunotherapy: past, present and future
Durham SR, Shamji MH.
Durham SR, Shamji MH. (2022). Allergen immunotherapy: past, present and future. Nat Rev Immunol, Epub ahead of print, 1-12.
Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis
Monach PA, Warner RL, Lew R, Tomasson G, Specks U, Stone JH, Fervenza FC, Hoffman GS, Kallenberg CGM, Langford CA, Seo P, St Clair EW, Spiera R, Johnson KJ, Merkel PA
Monach PA, Warner RL, Lew R, Tomasson G, Specks U, Stone JH, Fervenza FC, Hoffman GS, Kallenberg CGM, Langford CA, Seo P, St Clair EW, Spiera R, Johnson KJ, Merkel PA (2022). Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA-Associated Vasculitis. ACR Open Rheumatology, 4 (2), 168-176.
Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission
Gamerith G, Mildner F, Merkel PA, Harris K, Cooney L, Lim N, Spiera R, Seo P, Langford CA, Hoffman GS, St Clair EW, Fervenza FC, Monach P, Ytterberg SR, Geetha D, Amann A, Wolf D, Specks U, Stone JH, Kronbichler A.
Gamerith G, Mildner F, Merkel PA, Harris K, Cooney L, Lim N, Spiera R, Seo P, Langford CA, Hoffman GS, St Clair EW, Fervenza FC, Monach P, Ytterberg SR, Geetha D, Amann A, Wolf D, Specks U, Stone JH, Kronbichler A. (2022). Association of baseline soluble immune checkpoints with the risk of relapse in PR3-ANCA vasculitis following induction of remission. Ann Rheum Dis, Epub ahead of print.
Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials
Mexhitaj I, Lim N, Fernandez-Velasco JI, Zrzavy T, Harris KM, Muraro PA, Villar LM, Bar-Or A, Cooney LA.
Mexhitaj I, Lim N, Fernandez-Velasco JI, Zrzavy T, Harris KM, Muraro PA, Villar LM, Bar-Or A, Cooney LA. (2022). Stabilization of leukocytes from cerebrospinal fluid for central immunophenotypic evaluation in multicenter clinical trials. J Immunol Methods, Epub ahead of print.
Synergistic targeting of immunologic pathways to empower durable tolerance therapies
Nepom, GT
Nepom, GT (2022). Synergistic targeting of immunologic pathways to empower durable tolerance therapies. Front Immunol, 13 (962177).
Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade
Shimozawa K, Contreras-Ruiz L, Sousa S, Zhang R, Bhatia U, Crisalli KC, Brennan LL, Turka LA, Markmann JF, Guinan EC.
Shimozawa K, Contreras-Ruiz L, Sousa S, Zhang R, Bhatia U, Crisalli KC, Brennan LL, Turka LA, Markmann JF, Guinan EC. (2022). Ex vivo generation of regulatory T cells from liver transplant recipients using costimulation blockade. Am J Transplant, 22 (2), 504-518.
Next Generation Pathology Detection of T cell-Antigen Presenting Cell Immune Synapses in Human Liver Allografts
Wood-Trageser MA, Lesniak D, Gambella A, Golnoski K, Feng S, Bucuvalas J, Sanchez-Fueyo A, Demetris AJ
Wood-Trageser MA, Lesniak D, Gambella A, Golnoski K, Feng S, Bucuvalas J, Sanchez-Fueyo A, Demetris AJ (2022). Next Generation Pathology Detection of T cell-Antigen Presenting Cell Immune Synapses in Human Liver Allografts. Hepatology, 77 (2), 355-366.
Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans
Tang, Q. Leung, J. Peng, Y. Sanchez-Fueyo, A. Lozano, JJ. Lam, A. Lee, K. Greenland, JR. Hellerstein, M. Fitch, M. Li, KW. Esensten, JH. Putnam, AL. Lares, A. Nguyen, V. Liu, W. Bridges, ND. Odim, J. Demetris, AJ. Levitsky, J. Taner, T. Feng, S.
Tang, Q. Leung, J. Peng, Y. Sanchez-Fueyo, A. Lozano, JJ. Lam, A. Lee, K. Greenland, JR. Hellerstein, M. Fitch, M. Li, KW. Esensten, JH. Putnam, AL. Lares, A. Nguyen, V. Liu, W. Bridges, ND. Odim, J. Demetris, AJ. Levitsky, J. Taner, T. Feng, S. (2022). Selective decrease of donor-reactive Tregs after liver transplantation limits Treg therapy for promoting allograft tolerance in humans. Sci Transl Med, 14, 669.
Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies
Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, Demetris AJ, Feng S.
Perito ER, Persyn E, Bucuvalas J, Martinez M, Mohammad S, Squires JE, Demetris AJ, Feng S. (2022). Graft Fibrosis Over 10 to 15 Years in Pediatric Liver Transplant Recipients: Multicenter Study of Paired, Longitudinal Surveillance Biopsies. Liver Transplantation, 28 (6), 1051-1062.
Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients
Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ.
Hübscher SG, Feng S, Gouw ASH, Haga H, Kang HJ, Kelly DA, Komuta M, Lesniak A, Popp BA, Verkade HJ, Yu E, Demetris AJ. (2022). Standardizing the histological assessment of late posttransplantation biopsies from pediatric liver allograft recipients. Liver Transplantation, 28 (9), 1475-1489.
Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives
Podestà MA, Sykes M.
Podestà MA, Sykes M. (2022). Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives. Front Immunol, 12 (791725).
A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes
Marwaha AK, Chow S, Pesenacker AM, Cook L, Sun A, Long SA, Yang JHM, Ward-Hartstonge KA, Williams E, Domingo-Vila C, Halani K, Harris KM, Tree TIM, Levings MK, Elliott T, Tan R, Dutz JP
Marwaha AK, Chow S, Pesenacker AM, Cook L, Sun A, Long SA, Yang JHM, Ward-Hartstonge KA, Williams E, Domingo-Vila C, Halani K, Harris KM, Tree TIM, Levings MK, Elliott T, Tan R, Dutz JP (2022). A phase 1b open-label dose-finding study of ustekinumab in young adults with type 1 diabetes. Immunotherapy Advances, 2 (1), 1 -13.
IL-6-targeted therapies directed to cytokine or receptor blockade drive distinct alterations in T cell function
Speake C, Habib T, Lambert K, Hundhausen C, Lord S, Dufort MJ, Skinner SO, Hu A, Kinsman M, Jones BE, Maerz MD, Tatum M, Hocking AM, Nepom GT, Greenbaum CJ, Buckner JH
Speake C, Habib T, Lambert K, Hundhausen C, Lord S, Dufort MJ, Skinner SO, Hu A, Kinsman M, Jones BE, Maerz MD, Tatum M, Hocking AM, Nepom GT, Greenbaum CJ, Buckner JH (2022). IL-6-targeted therapies directed to cytokine or receptor blockade drive distinct alterations in T cell function. JCI Insight, 7 (22), e159436.
Differential Induction of Allergen-specific IgA Responses following Timothy Grass Subcutaneous and Sublingual Immunotherapy
Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane Ellen, Layhadi JA, Wurtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR
Shamji MH, Larson D, Eifan A, Scadding GW, Qin T, Lawson K, Sever ML, Macfarlane Ellen, Layhadi JA, Wurtzen PA, Parkin RV, Sanda S, Harris KM, Nepom GT, Togias A, Durham SR (2021). Differential Induction of Allergen-specific IgA Responses following Timothy Grass Subcutaneous and Sublingual Immunotherapy. J Allergy Clin Immunol, S0091-6749 (21), 00552-2.
Evolution of epitope-specific IgE and IgG 4 antibodies in children enrolled in the LEAP trial
Suarez-Farinas M, Suprun M, Bahnson HT, Raghunathan R, Getts R, duToit G, Lack G, Sampson HA
Suarez-Farinas M, Suprun M, Bahnson HT, Raghunathan R, Getts R, duToit G, Lack G, Sampson HA. (2021). Evolution of epitope-specific IgE and IgG 4 antibodies in children enrolled in the LEAP trial. The Journal of Allergy and Clinical Immunology, S0091-6749 (21).
EAACI guideline: Preventing the development of food allergy in infants and young children
Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, Arshad H, Bahnson HT, Beyer K, Boyle R, Du Toit G, Ebisawa M, Eigenmann P, Grimshaw K, Hoest A, Jones C, Lack G, Nadeau K, O'Mahony L, Szajewska H, Venter C, Verhasselt V, Wong GWK, Roberts G
Halken S, Muraro A, de Silva D, Khaleva E, Angier E, Arasi S, Arshad H, Bahnson HT, Beyer K, Boyle R, Du Toit G, Ebisawa M, Eigenmann P, Grimshaw K, Hoest A, Jones C, Lack G, Nadeau K, O'Mahony L, Szajewska H, Venter C, Verhasselt V, Wong GWK, Roberts G (2021). EAACI guideline: Preventing the development of food allergy in infants and young children. Pediatric Allergy and Immunology, Online ahead of print.
Accurate and reproducible diagnosis of peanut allergy using epitope mapping
Suarez-Farinas M, Suprun M, Kearney P, Getts R, Grishina G, Hayward C, Luta D, Porter A, Witmer M, Du Toit G, Lack G, Chinthrajah RS, Galli SJ, Nadeau K, Sampson H
Suarez-Farinas M, Suprun M, Kearney P, Getts R, Grishina G, Hayward C, Luta D, Porter A, Witmer M, Du Toit G, Lack G, Chinthrajah RS, Galli SJ, Nadeau K, Sampson H (2021). Accurate and reproducible diagnosis of peanut allergy using epitope mapping. Allergy, 76 (12), 3789-3797.
Advancing Food Allergy Through Omics Sciences
Irizar H, Kanchan K, Mathias RA, Bunyavanich S.
Irizar H, Kanchan K, Mathias RA, Bunyavanich S. (2021). Advancing Food Allergy Through Omics Sciences. J Allergy Clin Immunol, 9 (1), 119-129.
Current insights into the genetics of food allergy
Kanchan K, Clay S, Irizar H, Bunyavanich S, Mathias RA
Kanchan K, Clay S, Irizar H, Bunyavanich S, Mathias RA (2021). Current insights into the genetics of food allergy. J Allergy Clin Immunol, 147 (1), 15-28.
Overview of oral tolerance induction for prevention of food allergy—Where are we now?
Krawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G.
Krawiec M, Fisher HR, Du Toit G, Bahnson HT, Lack G. (2021). Overview of oral tolerance induction for prevention of food allergy—Where are we now?. Allergy, 76 (9), 2684-2698.
A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis
McKinney EF, Cuthbertson I, Harris KM, Smilek D, Connor C, Manferrari G, Carr EJ, Zamvil SS, Smith KGC
McKinney EF, Cuthbertson I, Harris KM, Smilek D, Connor C, Manferrari G, Carr EJ, Zamvil SS, Smith KGC (2021). A CD8 + NK cell transcriptomic signature associated with clinical outcome in relapsing remitting multiple sclerosis. Nat Commun, 12 (1), 635.
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial
Harris KM, Smilek DE, Byron M, Lim N, Barry WT, McNamara J, Garcet S, Konrad RJ, Stengelin M, Bathala P, Korman NJ, Feldman SR, Boh EE, Barber K, Laumann AE, Helfrich YR, Krueger GG, Sofen H, Bissonnette R, Krueger JG
Harris KM, Smilek DE, Byron M, Lim N, Barry WT, McNamara J, Garcet S, Konrad RJ, Stengelin M, Bathala P, Korman NJ, Feldman SR, Boh EE, Barber K, Laumann AE, Helfrich YR, Krueger GG, Sofen H, Bissonnette R, Krueger JG (2021). Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial. JAMA Dermatol., 157 (11), 1306-1315.
Circulating autoreactive proteinase 3 + B cells and tolerance checkpoints in ANCA-associated vasculitis
Berti A, Hillion S, Hummel AM, Son YM, Chriti N, Peikert T, Carmona EM, Abdulahad WH, Heeringa P, Harris KM, St Clair EW, Brunetta P, Fervenza F, Langford C, Kallenberg C, Merkel P, Monach PA, Seo P, Spiera RF, Stone JH, Grandi G, Sun J, Pers JO, Specks U, Cornec D
Berti A, Hillion S, Hummel AM, Son YM, Chriti N, Peikert T, Carmona EM, Abdulahad WH, Heeringa P, Harris KM, St Clair EW, Brunetta P, Fervenza F, Langford C, Kallenberg C, Merkel P, Monach PA, Seo P, Spiera RF, Stone JH, Grandi G, Sun J, Pers JO, Specks U, Cornec D (2021). Circulating autoreactive proteinase 3 + B cells and tolerance checkpoints in ANCA-associated vasculitis. JCI Insight, 6 (22), e150999.
Uncovering Pathways to Personalized Therapies in Type 1 Diabetes
Linsley PS, Greenbaum CJ, GT Nepom
Linsley PS, Greenbaum CJ, GT Nepom (2021). Uncovering Pathways to Personalized Therapies in Type 1 Diabetes. Diabetes, 7 (4), 831-841.
Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR
Shaked O, Demetris J, Levitsky J, Feng S, Loza BL, Punch J, Reyes J, Klintmalm G, Jackson W, DesMarais M, Sayre P, Shaked A, Reddy KR (2021). Impact of Donor and Recipient Clinical Characteristics and Hepatic Histology on Steatosis/Fibrosis Following Liver Transplantation. Transplantation, Online ahead of print.
Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells
Tanimine N, Burrell BE, Deng K, Rickert C, Lee KM, Feeney N, Pardo J, LeGuern C, Markmann JF
Tanimine N, Burrell BE, Deng K, Rickert C, Lee KM, Feeney N, Pardo J, LeGuern C, Markmann JF (2021). Detection of alloreactive T cells from cryopreserved human peripheral blood mononuclear cells. J Immunol Methods, 491 (112987).
Integrated Analysis Toolset for Defining and Tracking Alloreactive T-cell Clones After Human Solid Organ and Hematopoietic Stem Cell Transplantation
Obradovic A, Shen Y, Sykes M, Fu J.
Obradovic A, Shen Y, Sykes M, Fu J. (2021). Integrated Analysis Toolset for Defining and Tracking Alloreactive T-cell Clones After Human Solid Organ and Hematopoietic Stem Cell Transplantation. Software Impacts, 10, 100142.
High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity
Fu J, Khosravi-Maharlooei M, Sykes M
Fu J, Khosravi-Maharlooei M, Sykes M (2021). High Throughput Human T Cell Receptor Sequencing: A New Window Into Repertoire Establishment and Alloreactivity. Front Immunol, 12.
